Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status by Lucas Gomes Sapienza, Maria Aparecida Conte Maia, Maria José Leite Gomes, André Mattar, Glauco Baiocchi, Vinicius Fernando Calsavara

Get full text

Systematic Review of Nomograms Used for Predicting Pathological Complete Response in Early Breast Cancer by Marcelo Antonini, Gabriel Duque Pannain, André Mattar, Odair Ferraro, Reginaldo Guedes Coelho Lopes, Juliana Monte Real, Lucas Miyake Okumura

Get full text

A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breas... by Roberto Hegg, André Mattar, João Nunes de Matos-Neto, José Luiz Pedrini, Sabina Bandeira Aleixo, Roberto Odebrecht Rocha, Renato Peixoto Cramer-Junior, Sylvie van-Eyll-Rocha

Get full text

Impact of the COVID-19 pandemic on the breast cancer early diagnosis program in Brazil by Marcelo Antonini, Denise J.P. da C. Pinheiro, Ana B.T. de M.B. Matos, Odair Ferraro, Andre Mattar, Lucas M. Okumura, Reginaldo G.C. Lopes, Juliana M. Real

Get full text

Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survival by Marcelo Antonini, André Mattar, Fernanda Grace Bauk Richter, Gabriel Duque Pannain, Marina Diógenes Teixeira, Andressa Gonçalves Amorim, Odair Ferraro, Reginaldo Coelho Guedes Lopes, Luiz Henrique Gebrim, Juliana Monte Real

Get full text

Does Pink October really impact breast cancer screening? by Marcelo Antonini, Denise Joffily Pereira da Costa Pinheiro, Gisela Rosa Franco Salerno, Ana Beatriz Tavares de Moura Brasil Matos, Odair Ferraro, André Mattar, Reginaldo Guedes Coelho Lopes, Juliana Monte Real

Get full text

Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil by André Mattar, Guilherme R. Fonseca, Murilo B. A. Romão, Jorge Y. Shida, Vilmar M. de Oliveira, Maria C. S. Bastos, Fabio Bagnoli, Jose F. Rinaldi, Monica M. Á. Stiepcich, Maria A. L. G. da Silva, Debbie M. Jakubowski, Calvin Chao, Sergio C. Oliveira, Luiz H. Gebrim

Get full text

Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study by Daniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, Flavia Rocha Paes, André Mattar, Jorge H. Santos Leal, Sérgio D. Simon, Ellias Magalhães Abreu Lima, Gustavo Werutsky, Gustavo H. Munhoz Piotto, José Bines, Lucas Petri Damiani, Ariane Macedo, Lígia Campos, Anna Maria Buehler

Get full text

Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology by Ruffo Freitas-Junior, Vilmar Marques de Oliveira, Antonio Luiz Frasson, Francisco Pimentel Cavalcante, Fabio Postiglione Mansani, André Mattar, Felipe Pereira Zerwes, Adriana Magalhães de Oliveira Freitas, Alessandra Borba Anton de Souza, Andrea P. Damin, Annamaria Massahud Rodrigues dos Santos, Carlos Alberto Ruiz, Clécio Ênio Murta de Lucena, Eduardo Camargo Millen, Fábio Bagnoli, Felipe Andrade, Frank Lane Braga Rodrigues, Gil Facina, Guilherme Novita, Jose Luiz Pedrini, José Pereira Guará, Leonardo Ribeiro Soares, Marcus Vinicius de Nigro Corpa, Mauro Passos, Nancy Cristina Ferraz de Lucena Ferreira, Nilceana Maya Aires Freitas, Rafael Henrique Szymanski Machado, Roberto Kepler da Cunha Amaral, Tomás Reinert, Vinicius Milani Budel

Get full text